![Giovanni Caforio, Biopharma Chief Executive Officer and Public Policy Advocate, to Speak at Stevens' 149th Commencement | Stevens Institute of Technology Giovanni Caforio, Biopharma Chief Executive Officer and Public Policy Advocate, to Speak at Stevens' 149th Commencement | Stevens Institute of Technology](https://images.ctfassets.net/mviowpldu823/ef76b3e958e2b41fa5aaf5ec08a3864d/9fcc5e28399c858a85662582ca0e3a33/Giovanni-Caforio-121416-020.jpg)
Giovanni Caforio, Biopharma Chief Executive Officer and Public Policy Advocate, to Speak at Stevens' 149th Commencement | Stevens Institute of Technology
![Bristol-Myers Squibb (BMY): Investment Case Getting Better And Better-A Great Time To Buy | Seeking Alpha Bristol-Myers Squibb (BMY): Investment Case Getting Better And Better-A Great Time To Buy | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1132313828/image_1132313828.jpg?io=getty-c-crop-4-3)
Bristol-Myers Squibb (BMY): Investment Case Getting Better And Better-A Great Time To Buy | Seeking Alpha
![In Conversation: Bristol-Myers Squibb (NYSE: BMY) CEO say he likes their Bay Area footprint - San Francisco Business Times In Conversation: Bristol-Myers Squibb (NYSE: BMY) CEO say he likes their Bay Area footprint - San Francisco Business Times](http://media.bizj.us/view/img/9271792/giovanni-caforio-15-009silo-large*750xx2640-3530-0-407.jpg)
In Conversation: Bristol-Myers Squibb (NYSE: BMY) CEO say he likes their Bay Area footprint - San Francisco Business Times
![Bristol Myers CEO Giovanni Caforio takes pay cut as 'human capital' metric drags down bonus | Fierce Pharma Bristol Myers CEO Giovanni Caforio takes pay cut as 'human capital' metric drags down bonus | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1616681816/Giovanni%20--%20New%20Brand.jpg/Giovanni%20--%20New%20Brand.jpg?VersionId=iuIaPflZBE2_fOmS_a_eZcZa78OviwL7)